Jim Cramer, host of CNBC’s popular finance show Mad Money, has been one of the most popular names in stock-picking in recent years. While his resume has its fair share of misses, he also had some home runs that helped build his reputation and made him an influential voice among Americans looking to boost their investment portfolio.
Cramer recently shared his predictions for stock picking in 2022, saying that investing in companies that “make things, that do tangible things, that innovate” is a path to success. He also revealed his top stock picks for the year, which aligns with this strategy. Check them out below.
Bausch Health
The reason why Cramer believes in Bausch Health is the fact that the Canadian pharmaceutical company recently split into three separate entities. As a result, he thinks the company will become more profitable and have increased growth as a result. It also doesn’t hurt that pharmaceutical products are always in demand regardless of inflation and price rises.
Chevron
According to Cramer, oil is still undervalued, so investing in American energy corporation Chevron will be a good decision. The company’s performance on the stock market, which includes a 5% rise in 2022 alone, backs this up.
Eli Lilly
In Cramer’s eyes, 2022 is the year to ride the pharmaceutical train and invest in American pharma giant Eli Lilly. He reasons that the company’s upcoming drugs for Alzheimer’s and diabetes should generate interest and strengthen its position on the market.
Honeywell
Honeywell perfectly fits the bill of a company that “makes things.” Thanks to its diverse offering of products and services in fields of aerospace, building technologies, and performance materials, among others, the global conglomerate is considered a safe bet.
